Description
RQD is a safe and effective proton pump inhibitor (PPI) that incorporates a trusted prokinetic agent in a sustained-release formulation. This combination not only reduces gastric acid production but also enhances gastrointestinal motility, promoting faster gastric emptying and improving overall digestive health.
The sustained-release technology ensures that the medication is released gradually over time, providing prolonged effects and improving patient adherence to treatment. RQD is particularly beneficial for individuals suffering from gastroesophageal reflux disease (GERD), functional dyspepsia, and other acid-related disorders, as it addresses both acid control and gastrointestinal movement, leading to better symptom relief and improved quality of life
Reviews
There are no reviews yet.